Researchers at Dongguk University in South Korea have developed an electromagnetic-field-responsive gene switch that can activate and deactivate genes inside living animals with remote, non-invasive stimulation. The system, described in a study published in Cell, uses a regulatory sequence associated with the mouse Lgr4 gene to control the timing, location, and intensity of gene expression. In experiments involving transgenic mice, electromagnetic field (EMF) exposure activated engineered genes throughout the body or in selected organs, while gene activity returned to baseline after stimulation stopped. The findings point toward a future in which gene therapies could be adjusted repeatedly and externally, rather than delivered as a single permanent intervention.
Gene switches are engineered DNA systems that allow researchers to turn selected genes on or off in response to a specific stimulus. They are increasingly being explored for regenerative medicine, cancer research, neuroscience, and the treatment of inherited disorders. Existing systems can respond to drugs, light, heat, ultrasound, or electrical signals, but each approach has limitations. Drug-controlled switches may produce unwanted effects or remain in the body longer than intended. Light can provide highly precise control but often struggles to reach tissues deep inside the body. Heat and ultrasound can also be difficult to restrict to a precise biological target. EMF, by contrast, can pass through the body without surgical access and can be generated by external devices, potentially including wearable systems.
The Dongguk team began by searching for genes that naturally respond to electromagnetic stimulation. Researchers exposed mouse brain tissue to an EMF measuring 2.0 millitesla at a frequency of 60 hertz, then analyzed changes in gene activity using single-cell RNA sequencing. This technique profiles RNA molecules in individual cells, allowing scientists to determine which genes are activated in particular cell populations rather than averaging signals across an entire tissue. Among the genes examined, Lgr4 showed a distinctive response to the electromagnetic field. The researchers subsequently isolated the regulatory promoter region controlling Lgr4 and used it as the foundation for an electromagnetic-field-inducible, or Ei, gene switch.
A promoter is a segment of DNA positioned near a gene that helps determine whether that gene is transcribed into messenger RNA. By placing a desired therapeutic or reporter gene under the control of an EMF-responsive promoter, scientists can make that gene dependent on electromagnetic stimulation. To test the system, the researchers connected the Ei regulatory element to a gene encoding green fluorescent protein, or GFP. GFP produces a bright signal that can be detected in cells and tissues, making it possible to observe when and where the switch was active. Mice carrying the engineered genetic construct displayed strong GFP production after EMF exposure, indicating that the promoter could function reliably inside a living organism.
The response was not limited to general activation throughout the body. When the researchers applied electromagnetic stimulation to selected regions, gene expression appeared in corresponding organs and tissues, demonstrating spatial control. The system also showed temporal reversibility. Once exposure ended, GFP activity declined and returned to its baseline level within approximately 24 hours. This behavior distinguishes the Ei switch from irreversible genetic changes and suggests that repeated cycles of activation and recovery may be possible. The researchers reported no detectable adverse effects during the study, although longer-term experiments and more detailed safety assessments will be needed before the technology can be considered for human use.
The study also investigated how cells detect the electromagnetic field. Using a genome-wide CRISPR-Cas9 knockout screen, the team systematically disrupted genes throughout the genome and identified those required for the EMF response. The screen pointed to cytochrome b5 type B, known as Cyb5b, a membrane-associated protein, as a critical component of the sensing mechanism. Follow-up experiments suggested that Cyb5b connects electromagnetic stimulation to changes in intracellular calcium. After EMF exposure, cells displayed rhythmic calcium influxes, producing oscillatory signals that appeared to act as a biological code for activating the Lgr4 promoter. The researchers describe Cyb5b as a possible molecular sensor for electromagnetic fields, although its precise physical mechanism remains to be established.
Calcium is one of the most widely used signaling systems in biology. Cells alter calcium concentrations to regulate processes including gene transcription, metabolism, secretion, contraction, and survival. In the Ei system, the pattern of calcium activity may be more important than a simple increase in calcium levels. The observed oscillations could activate downstream transcription factors or signaling pathways that bind to the Lgr4 promoter and initiate gene expression. Understanding this pathway will be essential for improving the switch’s sensitivity and selectivity, determining whether different EMF frequencies generate distinct cellular responses, and establishing how the system behaves across different tissues and species.
The researchers explored several potential biomedical applications in mice. In one set of experiments, they used the system to develop an Alzheimer’s disease model that separates brain aging-related changes from the accumulation of amyloid-beta plaques. This could help researchers investigate biological aging and neurodegeneration as partially independent processes, rather than treating plaque deposition as the sole driver of disease. In aged and progeroid mice, repeated EMF stimulation was used to induce partial cellular reprogramming. The treatment improved several molecular markers associated with aging without producing detectable harmful effects in the reported experiments. Partial reprogramming aims to restore youthful cellular characteristics while avoiding the complete loss of cellular identity that can occur during full reprogramming.
Another application focused on serotonin signaling and depression-like behavior. The team used the Ei switch to regulate the expression of Tph2, a gene involved in serotonin production in neurons. EMF-controlled activation of Tph2 restored serotonin levels and reduced depression-like behaviors in mice. These results illustrate how a remotely controlled gene switch might eventually be adapted to regulate neurochemical pathways, although behavioral findings in animals cannot be directly translated into clinical treatment. Human neurological disorders involve complex networks of cells and environmental factors, and any therapeutic system would need to demonstrate precise targeting, stable performance, and a strong safety profile.
The study’s authors say the platform could eventually shift gene therapy toward adjustable, real-time treatment. Instead of receiving a one-time dose that permanently alters gene activity, a patient might receive cells or genetic material whose behavior could be regulated externally by a physician or a wearable EMF device. Such an approach could be particularly valuable for therapies requiring changing doses, intermittent activation, or rapid shutdown in response to side effects. However, the current findings remain preclinical. The biological mechanism linking EMF, Cyb5b, calcium oscillations, and Lgr4 promoter activation requires further investigation, and the system must be tested for tissue specificity, immune responses, dose control, long-term safety, and effectiveness in larger animal models. If those challenges can be addressed, the Ei gene switch could become a versatile tool for remotely controlling gene expression in regenerative medicine and neurological disease research.
Subject of Research: Animals
Article Title: Electromagnetic field-inducible in vivo gene switch for remote spatiotemporal control of gene expression
News Publication Date: 28 May 2026
Web References: https://doi.org/10.1016/j.cell.2026.03.029
References: Electromagnetic field-inducible in vivo gene switch for remote spatiotemporal control of gene expression, Cell, DOI: 10.1016/j.cell.2026.03.029
Keywords
Electromagnetic fields, gene switches, gene expression, Lgr4, Cyb5b, calcium signaling, CRISPR-Cas9, Alzheimer’s disease, cellular reprogramming, regenerative medicine, neuroscience, gene therapy
Tags: advanced DNA regulatory systemscancer and neuroscience gene regulationelectromagnetic stimulation for gene controlelectromagnetic-field-responsive gene switchexternal control of gene activitygene therapy with electromagnetic fieldsnon-invasive gene regulationprogrammable gene expression systemsregenerative medicine gene switchesremote gene activation in living animalsreversible gene activation techniquestransgenic mice gene therapy
